2020
DOI: 10.1080/19490976.2020.1782158
|View full text |Cite
|
Sign up to set email alerts
|

Hemolysin BL from novel Bacillus toyonensis BV-17 induces antitumor activity both in vitro and in vivo

Abstract: The gut microbiota plays an important role in cancer development and immunotherapy. Bacterial toxins have enormous antitumor potential due to their cytotoxicity and ability to activate the immune system. Using 16S rRNA gene sequencing, we compared the gut microbiota composition of fecal samples from healthy individuals and patients with colorectal cancer (CRC) and observed that the genus Bacillus was common in the healthy donors but was absent in the CRC patients. Further, we isolated a novel Bacillus toyonens… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 28 publications
0
9
0
Order By: Relevance
“…For instance, SCFAs produced by the healthy human bacterium E. coli KUB-36 strain exhibited anticancer and anti-inflammatory activities by affecting the inflammatory reactions in lipopolysaccharide-induced THP-1 macrophage cells and by suppressing the proinflammatory cytokines IL-1β, IL-6, IL-8, and TNF-α whil promoting the expression of anti-inflammatory cytokine IL-10 ( 123 ). Some proteins (e.g., hemolysin BL reported from Bacillus toyonensis ) and polysaccharides (e.g., polysaccharide A from Bacteroides fragilis ) directly synthesized by specific members of the microbiome exhibited beneficial effects against cancers by modulating the immune response ( 125 , 126 ).…”
Section: Microbiome-derived Anticancer or Cancer-promoting Moleculesmentioning
confidence: 99%
See 2 more Smart Citations
“…For instance, SCFAs produced by the healthy human bacterium E. coli KUB-36 strain exhibited anticancer and anti-inflammatory activities by affecting the inflammatory reactions in lipopolysaccharide-induced THP-1 macrophage cells and by suppressing the proinflammatory cytokines IL-1β, IL-6, IL-8, and TNF-α whil promoting the expression of anti-inflammatory cytokine IL-10 ( 123 ). Some proteins (e.g., hemolysin BL reported from Bacillus toyonensis ) and polysaccharides (e.g., polysaccharide A from Bacteroides fragilis ) directly synthesized by specific members of the microbiome exhibited beneficial effects against cancers by modulating the immune response ( 125 , 126 ).…”
Section: Microbiome-derived Anticancer or Cancer-promoting Moleculesmentioning
confidence: 99%
“…The active molecule, a polysaccharide derivative, induced the expression of proinflammatory agents such as TNFα produced by dendritic cells and provided one possible mechanism for the association between R. gnavus and inflammatory disease ( 147 ). Another example based on bioactivity-guided fractionation is the identification of the antitumor molecule hemolysin BL from a fraction obtained from the supernatant of B. toyonensis BV-17, a member of the healthy human gut microbiome ( 125 ). In this study, the genus Bacillus was associated with healthy subjects and was absent in patients with colorectal cancer as revealed by 16S rRNA comparative metagenomics of the microbiome in both groups.…”
Section: Bioactivity-guided Fractionationmentioning
confidence: 99%
See 1 more Smart Citation
“…Abnormal immune responses to bacteria out of balance may disrupt this homeostasis and are related to human IBD ( Le Chatelier et al, 2013 ). Several studies have shown that intestinal flora affects intestinal mucosal immune function, intestinal cell metabolism and renewal and other processes, which can cause obesity, diabetes, malignant tumors, toxemia and IBD ( Chen et al, 2020 ; Ma et al, 2020 ; Wang et al, 2020 ). Therefore, exploring the role of the intestinal flora in the occurrence and development of UC, and restoring the balance of disordered flora is of great significance for the treatment of UC.…”
Section: Discussionmentioning
confidence: 99%
“…Significant differences were determined using one-way analysis of variance (ANOVA). Statistical differences in 16S rRNA high-throughput sequencing were assessed using Tukey’s HSD ( Li H. et al, 2020 ) , Chen et al, 2020 ). p < 0.05 was considered statistically significant.…”
Section: Methodsmentioning
confidence: 99%